India Dialysis Market Analysis Report 2022 to 2030

India Dialysis Market Analysis

$ 3999

India's dialysis market is projected to grow from $2.113 Bn in 2022 to $4.368 Bn by 2030, registering a CAGR of 9.50% during the forecast period of 2022 to 2030. The incidence of chronic kidney disease in India is on the rise due to factors such as diabetes and hypertension, which are becoming more prevalent in the country. This is driving the demand for dialysis treatment. Fresenius Medical Care is one of the leading players in the market, with a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services.

ID: IN10INPH010 CATEGORY: Pharmaceuticals GEOGRAPHY: India AUTHOR: Shivam Zalke

Buy Now

India Dialysis Market Executive Summary

India's dialysis market is projected to grow from $2.113 Bn in 2022 to $4.368 Bn by 2030, registering a CAGR of 9.50% during the forecast period of 2022 to 2030.

The Indian dialysis market is growing at a significant rate, driven by factors such as an increasing prevalence of chronic kidney disease (CKD), a growing geriatric population, and an increasing awareness of the availability and benefits of dialysis treatment.

Some of the key players in the Indian dialysis market include Fresenius Medical Care, Baxter International, and Nipro Medical Corporation. These companies have a significant presence in the market and offer a wide range of products and services for dialysis treatment. Other notable companies in the market include DaVita, Narayana Health, and Apollo Hospitals.

The government of India has implemented several policies and regulations to support the development of the dialysis market in the country. Some of these include the National Dialysis Services Program, which aims to increase access to dialysis services in underserved areas, and the National Health Policy, which aims to provide universal access to healthcare services, including dialysis. The government also provides financial assistance to patients for dialysis treatment through the National Health Mission.

India also has a large number of private players, which are also playing a major role in the market. Many private players are also offering dialysis services in rural areas and small towns, which is increasing the reach of dialysis services and making them more affordable for the people.

Overall, the dialysis market in India is expected to continue to grow at a significant rate in the coming years, driven by factors such as an increasing prevalence of CKD, a growing geriatric population, and increasing awareness of the availability and benefits of dialysis treatment.

india dialysis market analysis

Market Dynamics

Market Drivers

The India dialysis market is driven by several factors, including:

Increasing prevalence of chronic kidney disease (CKD): The incidence of CKD in India is on the rise due to factors such as diabetes and hypertension, which are becoming more prevalent in the country. This is driving the demand for dialysis treatment
Growing geriatric population: As the population of India ages, the number of people with kidney failure is expected to increase, which will drive the demand for dialysis treatment
Increasing awareness of the availability and benefits of dialysis treatment: There is an increasing awareness among the population of India about the availability and benefits of dialysis treatment, which is driving the demand for the treatment
Government support: The government of India has implemented several policies and regulations to support the development of the dialysis market in the country. Such as National Dialysis Services Program, National Health Policy, and financial assistance to patients for dialysis treatment through the National Health Mission
Private players: India has a large number of private players which are also playing a major role in the market. Many private players are also offering dialysis services in rural areas and small towns, which is increasing the reach of dialysis services and making them more affordable for the people
Rising demand for home-based dialysis: With the advancement of technology and increasing awareness, home-based dialysis is becoming more popular in India, as it is more convenient and less expensive than in-center dialysis
Increasing healthcare expenditure: The rising healthcare expenditure in the country is driving the growth of the dialysis market

Overall, these drivers are expected to continue to support the growth of the dialysis market in India in the coming years.

Competitive Landscape

Key Players

Some key players in the India dialysis market include Fresenius Medical Care, Baxter International, Nipro Medical Corporation, Narayana Health, Apollo Hospitals, and DaVita. These companies have a significant presence in the market and offer a wide range of products and services for dialysis treatment.

Fresenius Medical Care is one of the leading players in the market, with a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services
Baxter International is another major player in the market, offering a wide range of dialysis products, including hemodialysis machines, dialysis concentrates, and dialysis services
Nipro Medical Corporation is a leading player in the market, offering a wide range of dialysis products, including hemodialysis machines, dialysis concentrates, and dialysis services
Narayana Health is one of the largest providers of dialysis services in India, with a network of over 50 hospitals and clinics across the country
Apollo Hospitals is a leading player in the market, offering a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services
DaVita is a leading player in the market, offering a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services

Other notable companies in the market include NephroPlus, Dr. Agarwal's Healthcare Limited, and Medanta – The Medicity.

Healthcare Policies and Regulatory Landscape

The Indian government has implemented several policies and regulations to support the development of the dialysis market in the country. Some of these include:

National Dialysis Services Program: The program aims to increase access to dialysis services in underserved areas by setting up dialysis centers in remote and rural areas
National Health Policy: The policy aims to provide universal access to healthcare services, including dialysis
Financial assistance to patients for dialysis treatment through the National Health Mission: The government provides financial assistance to patients for dialysis treatment through the National Health Mission
Medical Devices Rules, 2017: The rules include regulations for the registration, inspection, and quality control of dialysis equipment and supplies
The Clinical Establishment Act (CEA): The Act regulates the functioning of clinical establishments and aims to improve the quality of healthcare services
Pradhan Mantri National Dialysis Programme (PMNDP): The program aims to provide free dialysis services to the economically weaker section of society in government and private hospitals
National Dialysis Services Program (NDSP): The program is aimed at increasing the availability of dialysis services in remote and underserved areas of the country

These policies and regulations have helped to create a favorable environment for the development of the dialysis market in India, and are expected to continue to support its growth in the future. However, the market still faces challenges such as a lack of infrastructure, a shortage of trained professionals, and high costs. Despite these challenges, the dialysis market in India is expected to continue to grow at a significant rate in the coming years, driven by factors such as an increasing prevalence of CKD, a growing geriatric population, and increasing awareness of the availability and benefits of dialysis treatment.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

India Dialysis Market Segmentation

The Dialysis Market is segmented as mentioned below:

By Type (Revenue, USD Billion):

Hemodialysis (HD)
- Conventional Hemodialysis
- Short daily hemodialysis
- Nocturnal hemodialysis
Peritoneal dialysis (PD)
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)

By Product & Services (Revenue, USD Billion):

Equipment
- Dialysis Machines
- Water Treatment Systems
- Others Dialysis Equipment
Consumables
- Dialyzers
- Catheters
- Other Dialysis Consumables
Dialysis Drugs
Services

By End User (Revenue, USD Billion):

In-center dialysis
Home dialysis

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.